Dihydropyridine Calcium Channel Blocker [EPC]

248250 reported adverse events

Drugs of this class: NIFEDIPINE FELODIPINE NIMODIPINE NISOLDIPINE ISRADIPINE AMLODIPINE AND VALSARTAN AMLODIPINE AMLODIPINE AND OLMESARTAN MEDOXOMIL CLEVIDIPINE CLEVIPIDINE FELODIPINE EXTENDED-RELEASE TABLETS OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLET 40/10/25 MG

These side effects are most commonly reported by patients taking drugs of the Dihydropyridine Calcium Channel Blocker [EPC] class:

# Side effect Count
0 FATIGUE 13870
1 DYSPNOEA 13371
2 DIARRHOEA 12723
3 NAUSEA 12554
4 DRUG INEFFECTIVE 11505
5 DIZZINESS 10510
6 HEADACHE 9572
7 PAIN 8671
8 ACUTE KIDNEY INJURY 8597
9 OFF LABEL USE 8433
See all common reactions for Dihydropyridine Calcium Channel Blocker [EPC]

Drugs of the Dihydropyridine Calcium Channel Blocker [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NON-CARDIOGENIC PULMONARY OEDEMA 235 0.3466
1 GINGIVAL HYPERTROPHY 327 0.3215
2 HYPERPARATHYROIDISM SECONDARY 653 0.2844
3 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 275 0.2823
4 NEPHROGENIC ANAEMIA 1173 0.2711
5 DISTRIBUTIVE SHOCK 224 0.2620
6 VASOPLEGIA SYNDROME 245 0.2549
7 GINGIVAL HYPERPLASIA 150 0.2488
8 BLOOD PRESSURE SYSTOLIC ABNORMAL 290 0.1888
9 BLOOD PRESSURE DIASTOLIC ABNORMAL 317 0.1780
See all enriched reactions for Dihydropyridine Calcium Channel Blocker [EPC]